Arcturus Therapeutics Holdings Inc. - 8-K Filing
Arcturus Therapeutics secures $50 million equity investment and expanded collaboration with Meiji Seika Pharma Co., Ltd. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $ARCT